Life Science Company
King Pharmaceuticals has acquired 2 companies of its own.
King Pharmaceuticals’ largest acquisition to date was in 2008, when it acquired Alpharma Pharmaceuticals for $16.0B. King Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Join Mergr and gain access to King Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Advisors 2